Frank E. Mott, M.D.

Primary Office

Temple Clinic
254-724-1713

Frank E. Mott, M.D., F.A.C.P.

  • Director, Lung Cancer Clinic
  • Program Director, Medical Oncology Fellowship
  • Co-Chair, Multidisciplinary Lung Cancer Committee

Faculty Rank - Texas A&M Health Science Center College of Medicine

Assistant Professor of Internal Medicine

Education

  • Texas A&M University College of Medicine, College Station, TX, M.D., 1988
  • University of Texas College of Pharmacy, Austin, TX, B.S., 1980

Specialty Training

  • Hematology/Oncology Fellowship, University of Wisconsin Comprehensive Care Center, Madison, WI, 1994
  • Internal Medicine Residency, University of Wisconsin Hospital and Clinics, Madison, WI, 1991

Scott & White Appointment

September 8, 1998

Board Certification

American Board of Internal Medicine: Medical Oncology

Publications and Research

  • Mott FE, Cable CT, Sharma N.
    Phase II study of an alternate carboplatin and gemcitabine dosing schedule in advanced non-small-cell lung cancer. Clin.Lung Cancer 2003; 5[3]:174-176.  
  • Donner LR, Mott FE, Tafur I.
    Cytokeratin-positive, CD45-negative primary centroblastic lymphoma of the adrenal gland: a potential for a diagnostic pitfall. Arch.Pathol.Lab Med. 2001; 125[8]:1104-1106.  
  • Korrapati V, Gaffney M, Larsson LG, Di Nunno L, Riggs M, Beissner RS, Rinehart JJ, Mott FE.
    Effect of HER2/neu expression on survival in non-small-cell lung cancer. Clin.Lung Cancer 2001; 2[3]:216-219.  

Scott & White • 2401 S. 31st St. • Temple, TX  76508
• 254-724-2111 • 800-792-3710 • 254-724-3038 (TTY)
©2010 Scott & White. All rights reserved.